Salvage high‐intensity focused ultrasound ( HIFU ) for locally recurrent prostate cancer after failed radiation therapy: Multi‐institutional analysis of 418 patients
Authors:
- 10 March 2017
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 119 (6) , 896-904
Abstract
Objective: To report the oncological outcome of salvage high‐intensity focused ultrasound (S‐ HIFU ) for locally recurrent prostate cancer after external beam radiotherapy ( EBRT ) from a multicentre database. Patients and Methods: This retrospective study comprises patients from nine centres with local recurrent disease after EBRT treated with S‐ HIFU from 1995 to 2009. The biochemical failure‐free survival ( bFFS ) rate was based on the ‘Phoenix’ definition ( PSA nadir + 2 ng/mL). Secondary endpoints included progression to metastasis and cancer‐specific death. Kaplan–Meier analysis was performed examining overall ( OS ), cancer‐specific ( CSS ) and metastasis‐free survival ( MFS ). Adverse events and quality of life status are reported. Results: In all, 418 patients with a mean ( SD ) follow‐up of 3.5 (2.5) years were included. The mean ( SD ) age was 68.6 (5.8) years and the PSA level before S‐ HIFU was 6.8 (7.8) ng/ mL . The median PSA nadir after S‐ HIFU was 0.19 ng/ mL . The OS , CSS and MFS rates at 7 years were 72%, 82% and 81%, respectively. At 5 years the bFFS rate was 58%, 51% and 36% for pre‐ EBRT low‐, intermediate‐ and high‐risk patients, respectively. The 5‐year bFFS rate was 67%, 42% and 22% for pre‐S‐ HIFU PSA level ≤4, 4–10 and ≥10 ng/ mL , respectively. Complication rates decreased after the introduction of specific post‐ RT parameters: incontinence (grade II or III ) from 32% to 19% ( P = 0.002); bladder outlet obstruction or stenosis from 30% to 15% ( P = 0.003); recto‐urethral fistula decreased from 9% to 0.6% ( P < 0.001). Study limitations include being a retrospective analysis from a registry with no control group. Conclusion: S‐ HIFU for locally recurrent prostate cancer after failed EBRT is associated with 7‐year CSS and MFS rates of >80% at a price of significant morbidity. S‐ HIFU should be initiated early following EBRT failureKeywords
This publication has 34 references indexed in Scilit:
- Salvage Cryoablation for Locally Recurrent Prostate Cancer Following Primary RadiotherapyEuropean Urology, 2012
- Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radio-Recurrent Prostate CancerEuropean Urology, 2011
- Radiorecurrent Prostate Cancer: An Emerging and Largely Mismanaged EpidemicEuropean Urology, 2011
- Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional CollaborationEuropean Urology, 2011
- 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century RadiotherapyEuropean Urology, 2010
- Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate CancerJournal of Urology, 2008
- PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate CancerEuropean Urology, 2008
- Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate‐specific antigen failureCancer, 2007
- SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: CONTEMPORARY OUTCOMESJournal of Urology, 2005